AstraZeneca Will Pay $425 Million to Settle Lawsuits Over Its Heartburn Medications

Britain’s AstraZeneca said it will pay $425 million to settle lawsuits in the United States that claimed its heartburn drugs Nexium and Prilosec caused chronic kidney disease.

AstraZeneca did not disclose specific terms of the agreement and said in a statement on Tuesday that it continues to believe the claims are without merit and admitted no wrongdoing.

It is the second British drugmaker to reach a settlement in the United States for its heartburn drug after GSK in June agreed to settle a U.S. lawsuit alleging its discontinued treatment Zantac caused cancer.

Read the source article at Yahoo Finance